Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smart scan guides esophageal cancer therapy: higher remission rates expected

NCT ID NCT07385664

First seen Feb 04, 2026 · Last updated May 20, 2026 · Updated 14 times

Summary

This study tests whether a special PET scan (FAPI-PET/CT) can help doctors pick the best treatment before surgery for people with esophageal cancer. After initial chemo-immunotherapy, the scan will show if the tumor is responding well. Good responders will continue chemo-immunotherapy, while poor responders will switch to chemoradiotherapy. The goal is to improve the chance of no cancer remaining at surgery (pCR). About 66 adults with resectable esophageal cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESECTABLE ESOPHAGEAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, 310022, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.